. "Appendix D: Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II." A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
miologic investigations, and infectious disease surveillance. He has published numerous scientific articles and two book chapters, and he is a diplomate of the American College of Veterinary Preventive Medicine. Dr. Bender received his DVM from the University of Minnesota.
Francisco Diez-Gonzalez is an associate professor in the Department of Food Science and Nutrition of the University of Minnesota. His research expertise is in food-safety microbiology, foodborne pathogens, safety of fresh fruits and vegetables, preharvest control of pathogenic E. coli, bioterrorism agents, and safety of organic food. Dr. Diez-Gonzalez teaches courses in food safety and food microbiology. He has served on the University of Minnesota Institutional Biosafety Committee, and he has advised undergraduate and graduate students. He is the author of more than 50 peer-reviewed publications and 10 book chapters. He is a member of the Editorial Boards of the Journal of Food Protection and the Journal of Food Analytical Methods. Dr. Diez-Gonzalez received his PhD in food science from Cornell University.
Kathryn M. Edwards (IOM) is Sarah H. Sell Chair in Pediatrics and the director of the Vanderbilt Vaccine Research Program of Vanderbilt University Medical Center. Her research focuses on the evaluation of vaccines for the prevention of infectious diseases in adults and children. She is a fellow of the Infectious Diseases Society of America and the American Academy of Pediatrics. Dr. Edwards has served as a member of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention and the Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration. She is a member of the Institute of Medicine, a member of the National Academies Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Selected Agents, and a past member of the National Academies Committee to Assess the Safety and Efficacy of the Anthrax Vaccine. Dr. Edwards received her MD from the University of Iowa College of Medicine.
Susan S. Ellenberg is professor of biostatistics and associate dean for clinical research in the University of Pennsylvania School of Medicine. Her research focuses on the design and analysis of clinical trials and the assessment of medical-product safety. Dr. Ellenberg is associate editor of Clinical Trials and of the Journal of the National Cancer Institute. She is a fellow of the American Statistical Association, the Society for Clinical Trials, and the American Association for the Advancement of Science. She has served as a member of the National Academies Planning Committee for the IOM Drug Safety Report: Resource Implications, Committee on the Assessment of the U.S. Drug Safety System, and Committee on Applied and Theoretical Statistics. Dr. Ellenberg received her PhD in mathematical statistics from George Washington University.